According to the Zhitong Finance App, Kang Fang Biotech (09926.HK) announced that on November 18, 2026, the trustee purchased 200,000 shares of the Company on the open market at a total cost of about HK$12 million. The Board of Directors of the Company believes that the purchase of shares reflects the Company's full confidence in its business outlook and future prospects. The purchase of shares is disbursed from the Company's existing available cash resources.

Zhitongcaijing · 1d ago
According to the Zhitong Finance App, Kang Fang Biotech (09926.HK) announced that on November 18, 2026, the trustee purchased 200,000 shares of the Company on the open market at a total cost of about HK$12 million. The Board of Directors of the Company believes that the purchase of shares reflects the Company's full confidence in its business outlook and future prospects. The purchase of shares is disbursed from the Company's existing available cash resources.